Eton Pharmaceuticals share price today

(ETON)

Eton Pharmaceuticals share price is $13.32 & ₹1,140.86 as on 1 Jan 2025, 2.30 'hrs' IST

$13.32

▲

0.29

(2.23%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Eton Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Eton Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Eton Pharmaceuticals. Get details on the Indian mutual funds that are investing in Eton Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Eton Pharmaceuticals's financials.

Eton Pharmaceuticals share price movements

Today's Low: $13.00
Today's High: $13.76
$13.32
2.4%
Downside
Day's Volatility :5.51%
Upside
3.19%
52 Weeks Low: $3.03
52 Weeks High: $13.98
$13.32
77.25%
Downside
52 Weeks Volatility :78.33%
Upside
4.72%

Eton Pharmaceuticals Returns

Period	Eton Pharmaceuticals Inc	Index (Russel 2000)
3 Months	92.76%	0.0%
6 Months	301.2%	0.0%
1 Year	187.69%	0.0%
3 Years	283.86%	-21.2%

Eton Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$13.03
Open	$12.95
Today's High	$13.7584
Today's Low	$13.0
Market Capitalization	$236.9M
Today's Volume	$192.0K
52 Week High	$13.98
52 Week Low	$3.03
Revenue TTM	$31.4M
EBITDA	$-5.3M
Earnings Per Share (EPS)	$-0.26
Profit Margin	-21.31%
Quarterly Earnings Growth YOY	-0.13%
Return On Equity TTM	-44.3%

How to invest in Eton Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Eton Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Eton Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Eton Pharmaceuticals or ETON on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Eton Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Eton Pharmaceuticals shares which would translate to 0.064 fractional shares of Eton Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Eton Pharmaceuticals, in just a few clicks!

Returns in Eton Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Eton Pharmaceuticals investment value today

Current value as on today

₹2,90,556

Returns

₹1,90,556

(+190.56%)

Returns from Eton Pharmaceuticals Stock

₹1,87,689 (+187.69%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Eton Pharmaceuticals

-27%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Eton Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Jan 2, 2025. -27% less investors are searching Eton Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Eton Pharmaceuticals

Opaleye Management Inc
10.76%
Vanguard Group Inc
3.98%
Nantahala Capital Management, LLC
3.87%
Westside Investment Management, Inc.
2.39%
Acuitas Investments, LLC
2.24%
EcoR1 Capital, LLC
2.19%

Analyst Recommendation on Eton Pharmaceuticals

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Eton Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Eton Pharmaceuticals

What analysts predicted

Downside of 2.4%

Current:

$13.32

Target:

$13.00

Insights on Eton Pharmaceuticals

Price Movement
In the last 6 months, ETON stock has moved up by 306.1%
Increasing Revenue
Revenue is up for the last 5 quarters, 7.02M → 10.32M (in $), with an average increase of 9.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -3.04M → 627.0K (in $), with an average increase of 585.0% per quarter

Eton Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Eton Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Eton Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Eton Pharmaceuticals Inc	12.69%	301.2%	187.69%	283.86%	283.86%
Neurocrine Biosciences Inc.	8.82%	-1.86%	2.84%	54.29%	23.23%
Haleon Plc Spon Ads	-1.75%	12.63%	14.39%	28.74%	28.74%
Zoetis Inc.	-7.92%	-6.88%	-15.55%	-30.38%	22.38%
Viatris Inc.	-4.23%	20.64%	9.5%	-12.39%	-23.81%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Eton Pharmaceuticals Inc	120.67	NA	NA	-0.17	-0.44	-0.12	NA	0.52
Neurocrine Biosciences Inc.	36.4	36.4	0.32	6.37	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.91	28.91	1.72	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.57	30.57	2.52	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Eton Pharmaceuticals Inc	Buy	$236.9M	283.86%	120.67	-21.31%
Neurocrine Biosciences Inc.	Buy	$13.8B	23.23%	36.4	17.21%
Haleon Plc Spon Ads	Buy	$43.1B	28.74%	28.91	10.75%
Zoetis Inc.	Buy	$73.5B	22.38%	30.57	26.55%
Viatris Inc.	Hold	$14.9B	-23.81%	224.4	-5.87%

About Eton Pharmaceuticals

eton pharmaceuticals, inc. is a deer park, illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the u.s. food and drug administration’s 505(b)(2) regulatory pathway. our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.

Organization	Eton Pharmaceuticals
Employees	30
CEO	Mr. Sean E. Brynjelsen
Industry	Health Technology

Management People of Eton Pharmaceuticals

Name	Title
Mr. Sean E. Brynjelsen	President, CEO & Director
Mr. James R. Gruber CPA	CFO, Treasurer & Secretary
Mr. David C. Krempa	Chief Business Officer
Danka Radosavljevic	Senior Vice President of Quality & Operations
Mr. Scott Grossenbach	Vice President of Sales Operations
Mr. Kevin Guthrie	Executive VP of Commercial Operations

Important FAQs about investing in Eton Pharmaceuticals from India :

What is Eton Pharmaceuticals share price today?

Eton Pharmaceuticals share price today stands at $13.32, Open: $12.95 ; Previous Close: $13.03 ; High: $13.76 ; Low: $13.00 ; 52 Week High: $13.98 ; 52 Week Low: $3.03. The stock opens at $12.95, after a previous close of $13.03. The stock reached a daily high of $13.76 and a low of $13.00, with a 52-week high of $13.98 and a 52-week low of $3.03.

Can Indians buy Eton Pharmaceuticals shares?

Yes, Indians can invest in the Eton Pharmaceuticals (ETON) from India.

With INDmoney, you can buy Eton Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Eton Pharmaceuticals at zero transaction cost.

How can I buy Eton Pharmaceuticals shares from India?

It is very easy to buy Eton Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Eton Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Eton Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Eton Pharmaceuticals stocks?

To start investing in Eton Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.